Oncology ****************************************************************************************** * Oncology ****************************************************************************************** *========================================================================================= * Experimental oncology *========================================================================================= covers mechanisms of regulations of basic cell biological programs connected with oncogene microenvironment, apoptosis, proliferation, differentiation, adhesion, migration, invasion mesenchymal transition, immunosurveilance). *========================================================================================= * Oncohaematology *========================================================================================= molecular regulatory mechanisms of blood cell differentiation and their pathologies. Basic translational research in the field. Namely childhood leukemias, morbus Hodgkin and haemat *========================================================================================= * Solid tumors *========================================================================================= namely neurooncology, oncogynaecology, oncourology, pancreatic and skin cancers. Individua radical surgical treatment, ultrasound implementation into the gynecological oncology, her and epigenetic alterations in prediction and early detection of cancer. Optimization of di and therapeutic processes, establishment of complex biobank. Studies of in vivo homing of cells, tumor immunology, monitoring of the response to treatment in multiple myeloma, extr photopheresis. Characteristics of the mechanisms of the effectiveness of anticancer agents circulating cancer cells, advanced techniques of radiotherapy. ****************************************************************************************** * Selected outputs ****************************************************************************************** • MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia. V N, Burda P, Basova P, Kulvait V, Pospisil V, Savvulidi F, Kokavec J, Necas E, Berkova A, Karban J, Mraz M, Pospisilova S, Mayer J, Trneny M, Zavadil J, Stopka T. Blood, (2011)11 IF: 9.898 • Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice. Basova P, Pospisil V, Burda P, Vargova K, Stanek L, Dluhosova M, Kuzmova E, Jonasova A, Steidl U, Laslo P, Sto (2014) 33(39):4735-45. IF: 8.56 • Stary, J., M. Zimmermann, M. Campbell, L. Castillo, E. Dibar, S. Donska, A. Gonzalez, S. Janic, J. Jazbec, J. Konja, E. Kaiserova, J. Kowalczyk, G. Kovacs, C. K. Li, E. Magyaros Stark, Y. Jabali, J. Trka, O. Hrusak, H. Riehm, G. Masera and M. Schrappe. "Intensive Ch Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Intercontinental Trial 2002." J Clin Oncol 32, no. 3, (2014): 174-84. IF=19,96 • Slamova, L., J. Starkova, E. Fronkova, M. Zaliova, L. Reznickova, F. W. van Delft, E. Vo Volejnikova, Z. Zemanova, K. Polgarova, G. Cario, M. Figueroa, T. Kalina, K. Fiser, J. P Bornhauser, M. Dworzak, J. Zuna, J. Trka, J. Stary, O. Hrusak and E. Mejstrikova. "Cd2-P Precursor Acute Lymphoblastic Leukemia with an Early Switch to the Monocytic Lineage." L 3 (2014): 609-20. IF=9,379 • Rob L, Škapa P, Robová H: Fertility- sparing surgery in patiens with cervical cancer. La (2011); 12, 192-200   (ISSN 1470-2045), IF=25.12 • Šedo A., Mentlein, R.(Eds.): Glioma Cell Biology, Springer pp., 1-468, (2014)-ISBN 978-3